Direkt zum Inhalt

Case details

Case Number: App_465221/2023

  • Patent number:
    EP4171654 - COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CDK9 INHIBITOR

  • Proceeding type: Application

  • Action/Application: Inanspruchnahme der Ausnahmeregelung

  • Applicants:
    AstraZeneca UK Limited | Daiichi Sankyo Company, Limited Represented by AstraZeneca UK Limited | Daiichi Sankyo Company, Limited

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-01 17:05:29